Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the familyBrendan P. Eckelman, Fiona L. Scott|EMBO Reports|2006Cited by 815
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in ChondrosarcomaVivek Subbiah, Brendan P. Eckelman, Anthony W. Tolcher et al.|Clinical Cancer Research|2023Cited by 40